LAMEA Hemodynamic Monitoring Devices Market

LAMEA Hemodynamic Monitoring Devices Market Size, Share & Industry Trends Analysis Report By Product (Monitors and Disposables), By System Type (Non-Invasive, Minimally Invasive and Invasive), By End Use, By Country and Growth Forecast, 2023 - 2030

Report Id: KBV-17549 Publication Date: September-2023 Number of Pages: 147
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Hemodynamic Monitoring Devices Market would witness market growth of 7.7% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 266.7 thousand Units, showcasing a growth of 9.1% (2023-2030).

New methods of hemodynamic monitoring have the potential to improve the management of cardiovascular patients during anaesthesia and postoperative care because they offer precise and repeatable measurements that can be used to identify hemodynamic changes and their causes, improve hemodynamic conditions like oxygen delivery to the tissues, and give feedback on the efficacy of therapeutic interventions. The switch to less invasive or non-invasive monitoring techniques and the shift from static to dynamic variables for assessing requirements like cardiac preload and fluid responsiveness further propel the market's expansion.

In addition, the market is expanding at a rate further accelerated by the widespread acceptance of sedentary lifestyles and the rising number of yearly surgeries. Critical congenital heart disease (CCHD) screening is becoming increasingly necessary, which presents a significant possibility for market expansion. The market's growth rate is fueled by attractive reimbursement policies and the unhealthily bad diet prevalent in large cities. The rise in R&D spending by public and commercial organizations for efficient treatments fuels the expansion of the market. The market is expected to grow due to the development of the healthcare infrastructure, particularly in emerging economies, the increasing emphasis on personalized medicine and tailored treatment methods, favorable reimbursement policies, and healthcare reforms that encourage the adoption of cutting-edge monitoring technologies.

The cases of heart attacks and heart-related diseases are on the rise in Brazil. The Agencia Brasil (the national public news agency, run by the Brazilian government) reported that the National Institute of Cardiology (INC) conducted a new study. According to this INC study, there was a noticeable increase in heart attack admissions in Brazil between 2008 and 2022. Additionally, it has been noted that many adults smoke in this region. Ultimately, this contributes to the rising heart disease in the UAE. A sedentary lifestyle is a primary factor in the increased risk of heart disease. Owing to all these factors, there will be an increased demand in the LAMEA region.

The Brazil market dominated the LAMEA Hemodynamic Monitoring Devices Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $29.2 Million by 2030. The Argentina market is estimated to grow at a CAGR of 8.3% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 7.4% during (2023 - 2030).

Based on Product, the market is segmented into Monitors and Disposables. Based on System Type, the market is segmented into Non-Invasive, Minimally Invasive and Invasive. Based on End Use, the market is segmented into Hospitals, Catheterization Labs, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Hemodynamic Monitoring Devices Market is Projected to reach USD 1.9 Billion by 2030, at a CAGR of 5.4%

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Edwards Lifesciences Corporation, GE HealthCare Technologies, Inc., Baxter International, Inc., ICU Medical, Inc., Masimo Corporation, Deltex Medical Group Plc., Sramek BioDynamics, Inc., Osypka Medical GmbH, Medtronic PLC, and Koninklijke Philips N.V.

Scope of the Study

Market Segments Covered in the Report:

By Product (Volume, Thousand Units, USD Million, 2019-2030)

  • Monitors
  • Disposables

By System Type (Volume, Thousand Units, USD Million, 2019-2030)

  • Non-Invasive
  • Minimally Invasive
  • Invasive

By End-use (Volume, Thousand Units, USD Million, 2019-2030)

  • Hospitals
  • Catheterization Labs
  • Others

By Country (Volume, Thousand Units, USD Million, 2019-2030)

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Edwards Lifesciences Corporation
  • GE HealthCare Technologies, Inc.
  • Baxter International, Inc.
  • ICU Medical, Inc.
  • Masimo Corporation
  • Deltex Medical Group Plc.
  • Sramek BioDynamics, Inc.
  • Osypka Medical GmbH
  • Medtronic PLC
  • Koninklijke Philips N.V.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo